Research Reports
S3V Vascular Unlisted Shares
S3V Vascular Share Price
PHYSICAL
PRIVATE LIMITED
Price Chart
1W
1M
1Y
MAX
High
₹475
Low
₹325
Return
46.15%
S3V Vascular Essentials
As of May 08, 2026, S3V VASCULAR TECHNOLOGIES LIMITED, Unlisted Shares are trading at ₹480.00 per share and face value is ₹10.00/share, with a 52-week high of ₹0.00 and 52-week low of ₹0.00. The minimun lot size is 500 shares, and the shares are traded on .
ISIN
INE0HGT01012
An International Securities Identification Number (ISIN) is a code that uniquely identifies a specific securities issue. The numbers are allocated by a country's respective national numbering agency (NNA).
Face Value
10
Value of a security, as stated by its issuer. It has no relation with market price of the stock.
Total Shares
1,35,89,284
Total shares or total number of shares outstanding represents the amount of stock on the open market, including shares held by institutional investors and restricted shares held by insiders and company officers.
Market Cap
652.29 Cr
Market capitalization is the aggregate valuation of the company based on its current share price and the total number of outstanding shares.
Profit After Tax
-3.3 Cr
It is the final profit left over after subtracting all operating and non operating items from net revenue.
Total Revenue
15.1 Cr
Gross income refers to the total income earned by an individual on a pay check before taxes and other deductions. It comprises all incomes received by an individual from all sources – including wages, rental income, interest income, and dividends.
P/E
-197.66
It is a valuation parameter that measures the company's current share price relative to its per-share earnings. Generally, high P/E is Overvalued & low P/E is Undervalued.
Sector
Health Care
A sector is an area in which businesses share the same or a related product or service. It can also be known as an industry or market that shares common operating characteristics
Sub-sector
Health care Equipments & supplies
Subsectors are the divisions of a sector. They are areas that vary from the rest of the sector substantially enough to justify creating a plan just for the subsector.
Category
Micro Cap
Category is defined as a class or division of things regarded as having particular shared characteristics.
Cashflow - Operations
-4.84 Cr
It indicates the amount of money a company brings in from its ongoing and regular operations over a fixed period of time.
About S3V Vascular
- S3V Vascular Technologies Limited is a medical technology company specializing in the development and manufacturing of cardiovascular and critical-care medical devices. Founded with a mission to innovate affordable, cutting-edge medical technologies, the company aims to reduce the duration and risk of surgical procedures while enhancing patient outcomes.
- S3V Vascular Technologies Limited was incorporated on August 9, 2011, as a private limited company and is headquartered in Mysuru, Karnataka. The company was promoted by Badari Narayan Nagaradagadde, a technologist with over 30 years of experience in the medical device industry, who previously worked under Dr. A.P.J. Abdul Kalam on developing low-cost cardiac stents. His sons, Dr. Vijaya Gopal (Managing Director) and Vishnu Shreyas (Whole-Time Director & CFO), now lead the R&D and Operations divisions respectively.
- The company is involved in the end-to-end design, development, and manufacturing of minimally invasive medical devices. Its product portfolio focuses on cardiovascular solutions.
- The company caters to both the domestic Indian market and international markets, supplying directly to hospitals and through distributors. Its products are designed to meet international quality standards while remaining affordable for emerging markets.
- S3V Vascular Technologies operates a manufacturing facility in the Hootagalli Industrial Area, Mysuru, Karnataka. This facility is equipped for the precise manufacturing of sterile medical devices. In 2024, the company raised significant funding (Series B) to further expand its manufacturing capabilities and support its entry into the neurovascular segment, with plans for a new dedicated facility at the Tamil Nadu Medical Devices Park.
Want to See a Detailed Investment Analysis?
Explore in-depth financial analysis, performance metrics, and key disclosures.
S3V Vascular Media
News
Articles
Videos
Frequently Asked Question (FAQs)
Where can I find the annual report of S3V VASCULAR TECHNOLOGIES LIMITED Ltd?
The annual report of S3V VASCULAR TECHNOLOGIES LIMITED Ltd is available in the annual report section.
How to buy S3V VASCULAR TECHNOLOGIES LIMITED Unlisted Shares?
Please find below the procedure for buying S3V VASCULAR TECHNOLOGIES LIMITED Unlisted Shares at Planify.
• 1. You confirm booking of S3V VASCULAR TECHNOLOGIES LIMITED Unlisted Shares with us at a trading price.
• 2. You provide your client master report (ask the broker if not available) along with PAN Card and Cancelled Cheque in case you are not transferring funds from the bank account as mentioned in the CMR Copy. These are KYC documents required as per SEBI regulations.
• 3. We will provide the bank details.
• 4. You need to transfer funds in that account.
• 5. Payment has to be done in RTGS/NEFT/IMPS CHEQUE TRANSFER. No CASH DEPOSIT.
• 6. Payment has to be done from the same account in which shares are to be credited.
• 7. We will transfer the shares in 24 hours if funds are credited before 2 pm.
Important Note: Please note that the lock-in period for selling S3V VASCULAR TECHNOLOGIES LIMITED Unlisted Shares is 6 months after listing. Hence you can’t sell S3V VASCULAR TECHNOLOGIES LIMITED Unlisted Shares which you bought in Pre-IPO for 6 months after its listing. i.e. You can sell it only after 6 months calculated from the listing date.
What is the lock-in period of S3V VASCULAR TECHNOLOGIES LIMITED Unlisted Shares?
Lock-in period of S3V VASCULAR TECHNOLOGIES LIMITED Unlisted Shares depends upon category of investors.
• 1. Venture Capital Funds or Alternate Investment Fund of Category -I or II, or Foreign Venture Capital Investor - lock-in Period of 6 months from the date of acquisition of S3V VASCULAR TECHNOLOGIES LIMITED Unlisted Shares.
• 2. Other Investors (include Retail, HNIs or Body Corporate) lock-in Period of 6 months from the date of listing of IPO of S3V VASCULAR TECHNOLOGIES LIMITED Unlisted Shares.
This new SEBI rule was introduced in the month of August-2021, wherein the SEBI has reduced the lock-in period previously from 1 year to 6 months to encourage more and more funds to be invested in startups which are going to public or IPO in near future. Reduction of lock-in is seen as big step and after that many PMS funds are advising their clients to invest in Pre-IPO shares to get the benefit of early stage investment.
See More
S3V Vascular
₹ 480
